DK1254162T3 - Kahalalid F og beslægtede forbindelser - Google Patents
Kahalalid F og beslægtede forbindelserInfo
- Publication number
- DK1254162T3 DK1254162T3 DK01904169T DK01904169T DK1254162T3 DK 1254162 T3 DK1254162 T3 DK 1254162T3 DK 01904169 T DK01904169 T DK 01904169T DK 01904169 T DK01904169 T DK 01904169T DK 1254162 T3 DK1254162 T3 DK 1254162T3
- Authority
- DK
- Denmark
- Prior art keywords
- kahalalid
- related compounds
- kahalalide
- leads
- preparing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- RCGXNDQKCXNWLO-WLEIXIPESA-N (2r)-n-[(2s)-5-amino-1-[[(2r,3r)-1-[[(3s,6z,9s,12r,15r,18r,19s)-9-benzyl-15-[(2r)-butan-2-yl]-6-ethylidene-19-methyl-2,5,8,11,14,17-hexaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent Chemical compound N([C@@H](CCCN)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H]1C(N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NC(/C(=O)N[C@H](C(=O)O[C@H]1C)C(C)C)=C\C)C(C)C)[C@H](C)CC)=O)C(=O)[C@H]1CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CCCC(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C RCGXNDQKCXNWLO-WLEIXIPESA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 229930194861 kahalalide Natural products 0.000 abstract 1
- 108010091711 kahalalide F Proteins 0.000 abstract 1
- 230000003278 mimic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Detergent Compositions (AREA)
- Steroid Compounds (AREA)
- Optical Record Carriers And Manufacture Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0002952.0A GB0002952D0 (en) | 2000-02-09 | 2000-02-09 | Process for producing kahalalide F compounds |
| PCT/GB2001/000576 WO2001058934A2 (en) | 2000-02-09 | 2001-02-09 | Kahalalide f and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1254162T3 true DK1254162T3 (da) | 2008-01-02 |
Family
ID=9885232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01904169T DK1254162T3 (da) | 2000-02-09 | 2001-02-09 | Kahalalid F og beslægtede forbindelser |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US7482429B2 (https=) |
| EP (3) | EP1829889A3 (https=) |
| JP (1) | JP5188665B2 (https=) |
| KR (1) | KR100871489B1 (https=) |
| CN (2) | CN1422278A (https=) |
| AT (1) | ATE371667T1 (https=) |
| AU (1) | AU783542B2 (https=) |
| BG (1) | BG65926B1 (https=) |
| BR (1) | BR0108213A (https=) |
| CA (1) | CA2399187C (https=) |
| CY (1) | CY1106992T1 (https=) |
| CZ (1) | CZ304258B6 (https=) |
| DE (1) | DE60130192T2 (https=) |
| DK (1) | DK1254162T3 (https=) |
| ES (1) | ES2292558T3 (https=) |
| GB (1) | GB0002952D0 (https=) |
| HU (1) | HUP0301817A3 (https=) |
| IL (2) | IL150981A0 (https=) |
| MX (1) | MXPA02007760A (https=) |
| NO (1) | NO331847B1 (https=) |
| NZ (1) | NZ520488A (https=) |
| PL (1) | PL207121B1 (https=) |
| PT (1) | PT1254162E (https=) |
| RU (1) | RU2280039C2 (https=) |
| SK (1) | SK11242002A3 (https=) |
| UA (1) | UA76949C2 (https=) |
| WO (1) | WO2001058934A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
| GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
| ES2256305T3 (es) | 2000-10-31 | 2006-07-16 | Pharma Mar, S.A. | Formulaciones de kahalalide f. |
| US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
| GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
| US7507708B2 (en) | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
| GB0321066D0 (en) * | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
| GB0408958D0 (en) * | 2004-04-22 | 2004-05-26 | Pharma Mar Sa | Convergent synthesis for kahalalide compounds |
| CN100396696C (zh) * | 2004-04-23 | 2008-06-25 | 中国科学院海洋研究所 | 一种海洋绿藻在提取抗肿瘤活性环肽组分中的应用 |
| WO2009052379A2 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
| AU2009209541A1 (en) * | 2008-01-30 | 2009-08-06 | Pharma Mar, S.A. | Improved antitumoral treatments |
| CN101965192A (zh) * | 2008-03-07 | 2011-02-02 | 法马马有限公司 | 改善的抗肿瘤治疗 |
| CN103641891B (zh) * | 2013-05-23 | 2017-03-22 | 深圳翰宇药业股份有限公司 | 一种制备Kahalalide F的方法 |
| CN113061089A (zh) | 2015-09-23 | 2021-07-02 | 凯瑞康宁生物工程（武汉）有限公司 | γ-羟基丁酸的前药及其组合物和用途 |
| CN110709386B (zh) | 2017-03-30 | 2022-06-07 | 凯瑞康宁生物工程（武汉）有限公司 | 双环杂芳基衍生物及其制备与用途 |
| HRP20231233T1 (hr) | 2017-04-27 | 2024-01-19 | Pharma Mar, S.A. | Antitumorski spojevi |
| ES2947089T3 (es) | 2018-09-30 | 2023-08-01 | Xwpharma Ltd | Compuestos como antagonistas del receptor histamínico 3 neuronal y usos de los mismos |
| KR102881504B1 (ko) | 2019-12-20 | 2025-11-06 | 엑스더블유파마 리미티드 | 4-발레릴옥시부티르산의 합성 방법 |
| CN115803017A (zh) | 2020-06-18 | 2023-03-14 | 凯瑞康宁生物工程有限公司 | 水溶性活性药物成分的药物造粒物 |
| AU2021292406B2 (en) | 2020-06-18 | 2024-03-14 | XWPharma Ltd. | Controlled release granulations of water-soluble active pharmaceutical ingredients |
| CN116261451A (zh) | 2020-07-24 | 2023-06-13 | 凯瑞康宁生物工程有限公司 | γ-羟基丁酸衍生物的药物组合物和药物动力学 |
| KR20230058151A (ko) | 2020-10-05 | 2023-05-02 | 엑스더블유파마 리미티드 | 감마-하이드록시부티르산 유도체의 변형된 방출 조성물 |
| EP4588471A3 (en) | 2021-03-19 | 2025-09-24 | XWPharma Ltd. | Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative |
| US20230338543A1 (en) * | 2022-04-21 | 2023-10-26 | Zevra Therapeutics, Inc. | Gamma-hydroxybutyrate delivering compounds and processes for making and using them |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US39496A (en) * | 1863-08-11 | Improvement in ratchet-drills | ||
| CU22545A1 (es) * | 1994-11-18 | 1999-03-31 | Centro Inmunologia Molecular | Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico |
| US4943533A (en) * | 1984-03-01 | 1990-07-24 | The Regents Of The University Of California | Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor |
| JPS6178719A (ja) * | 1984-09-25 | 1986-04-22 | Tanabe Seiyaku Co Ltd | 総合輸液剤 |
| GR870129B (en) * | 1987-01-27 | 1987-02-04 | Giatzidis Ippokratis | Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis |
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| EP0531472B1 (en) * | 1991-03-06 | 2003-08-13 | MERCK PATENT GmbH | Humanized monoclonal antibodies |
| ATE205854T1 (de) * | 1991-11-19 | 2001-10-15 | Amylin Pharmaceuticals Inc | Peptide als amylin-agonisten und ihre verwendung |
| US5849704A (en) * | 1991-12-20 | 1998-12-15 | Novo Nordisk A/S | Pharmaceutical formulation |
| AU661533B2 (en) * | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
| GB9302046D0 (en) * | 1993-02-03 | 1993-03-24 | Pharma Mar Sa | Antiumoral compound-v |
| US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
| US5932189A (en) * | 1994-07-29 | 1999-08-03 | Diatech, Inc. | Cyclic peptide somatostatin analogs |
| US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| US5747498A (en) * | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| JP3927248B2 (ja) | 1995-07-11 | 2007-06-06 | 第一製薬株式会社 | Ｈｇｆ凍結乾燥製剤 |
| ID19609A (id) * | 1996-07-13 | 1998-07-23 | Glaxo Group Ltd | Senyawa-senyawa heterosiklik |
| US6235883B1 (en) * | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| AU7476198A (en) * | 1997-05-09 | 1998-11-27 | General Hospital Corporation, The | Cell proliferation related genes |
| RS49779B (sr) * | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| US6200598B1 (en) * | 1998-06-18 | 2001-03-13 | Duke University | Temperature-sensitive liposomal formulation |
| WO2000031048A1 (en) * | 1998-11-19 | 2000-06-02 | Warner-Lambert Company | N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases |
| US7311924B2 (en) * | 1999-04-01 | 2007-12-25 | Hana Biosciences, Inc. | Compositions and methods for treating cancer |
| UA74803C2 (uk) * | 1999-11-11 | 2006-02-15 | Осі Фармасьютікалз, Інк. | Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування |
| GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
| CA2406743A1 (en) * | 2000-04-28 | 2001-11-08 | The Trustees Of The University Of Pennsylvania | Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
| ES2256305T3 (es) | 2000-10-31 | 2006-07-16 | Pharma Mar, S.A. | Formulaciones de kahalalide f. |
| US20050054555A1 (en) | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
| GB0304367D0 (en) | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
| US7507708B2 (en) | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
| GB0321066D0 (en) * | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
| GB0408958D0 (en) * | 2004-04-22 | 2004-05-26 | Pharma Mar Sa | Convergent synthesis for kahalalide compounds |
-
2000
- 2000-02-09 GB GBGB0002952.0A patent/GB0002952D0/en not_active Ceased
-
2001
- 2001-02-09 AU AU32086/01A patent/AU783542B2/en not_active Ceased
- 2001-02-09 IL IL15098101A patent/IL150981A0/xx unknown
- 2001-02-09 PT PT01904169T patent/PT1254162E/pt unknown
- 2001-02-09 DE DE60130192T patent/DE60130192T2/de not_active Expired - Lifetime
- 2001-02-09 EP EP07010878A patent/EP1829889A3/en not_active Withdrawn
- 2001-02-09 SK SK1124-2002A patent/SK11242002A3/sk not_active Application Discontinuation
- 2001-02-09 MX MXPA02007760A patent/MXPA02007760A/es active IP Right Grant
- 2001-02-09 CN CN01807743A patent/CN1422278A/zh active Pending
- 2001-02-09 EP EP01904169A patent/EP1254162B1/en not_active Expired - Lifetime
- 2001-02-09 ES ES01904169T patent/ES2292558T3/es not_active Expired - Lifetime
- 2001-02-09 PL PL356800A patent/PL207121B1/pl unknown
- 2001-02-09 CN CN200810178807.9A patent/CN101597326B/zh not_active Expired - Fee Related
- 2001-02-09 WO PCT/GB2001/000576 patent/WO2001058934A2/en not_active Ceased
- 2001-02-09 BR BR0108213-2A patent/BR0108213A/pt not_active IP Right Cessation
- 2001-02-09 KR KR1020027010355A patent/KR100871489B1/ko not_active Expired - Fee Related
- 2001-02-09 AT AT01904169T patent/ATE371667T1/de active
- 2001-02-09 HU HU0301817A patent/HUP0301817A3/hu unknown
- 2001-02-09 DK DK01904169T patent/DK1254162T3/da active
- 2001-02-09 CZ CZ2002-2740A patent/CZ304258B6/cs not_active IP Right Cessation
- 2001-02-09 US US10/182,881 patent/US7482429B2/en not_active Expired - Fee Related
- 2001-02-09 EP EP10178150A patent/EP2258715A1/en not_active Withdrawn
- 2001-02-09 JP JP2001558081A patent/JP5188665B2/ja not_active Expired - Fee Related
- 2001-02-09 NZ NZ520488A patent/NZ520488A/en not_active IP Right Cessation
- 2001-02-09 CA CA2399187A patent/CA2399187C/en not_active Expired - Fee Related
- 2001-02-09 RU RU2002123877/04A patent/RU2280039C2/ru active
- 2001-09-02 UA UA2002097267A patent/UA76949C2/uk unknown
-
2002
- 2002-07-30 IL IL150981A patent/IL150981A/en not_active IP Right Cessation
- 2002-08-08 NO NO20023749A patent/NO331847B1/no not_active IP Right Cessation
- 2002-08-21 BG BG107020A patent/BG65926B1/bg unknown
-
2007
- 2007-11-08 CY CY20071101442T patent/CY1106992T1/el unknown
-
2008
- 2008-08-25 US US12/198,013 patent/US20080318849A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1254162T3 (da) | Kahalalid F og beslægtede forbindelser | |
| ATE476155T1 (de) | In-vitro herstellung von transplantierbarem knorpelgewebe | |
| ATE403407T1 (de) | Biegsame medizinische vorrichtung | |
| PL358451A1 (pl) | Sposób sterylizacji materiałów biologicznych | |
| NO910796D0 (no) | Forbedrede biologiske insektkontrollmidler og fremgangsmaater ved bruk derav. | |
| DE122011100046I1 (de) | In vitro kulturprozess fur verschiedene stadien von gewebeparasiten. | |
| DE59203610D1 (de) | Reaktor zur Durchführung biologischer Reaktionen mittels Biokatalysatoren. | |
| FI964821A7 (fi) | Menetelmä parannettujen biologisten torjunta-aineiden valmistamiseksi | |
| DE69724214D1 (de) | Verbessertes Kultivationsverfahren | |
| NO20006035D0 (no) | Dyrkingsanlegg for akvatiske organismer | |
| DE60042753D1 (de) | Von antibiotika | |
| DE69508572D1 (de) | Methode zur kultivierung von tierzellen | |
| DK179188D0 (da) | Fremgangsmaade til dyrkning af mikroorganismer | |
| ES2175823T3 (es) | Procedimiento de preparacion de mequitazina e intermedio de sintesis. | |
| DK126288A (da) | Fremgangsmaade til fremstilling af polychlorphosphazen | |
| KR970048709U (ko) | 양액 재배용 베드벤치 | |
| ES2095544T3 (es) | Metodo para la preparacion de compuestos de 2-aril-5-trifluormetilpirrol. | |
| DE69117438D1 (de) | Verfahren zur Herstellung von insektiziden, nematiziden und akariziden, in 4-Stellung substituierten 5-(Trifluormethyl) pyrrol-3-nitril-Verbindungen | |
| DK0818464T3 (da) | Methylsulfomycin I, fremgangsmåde til dets fremstilling og dets anvendelse | |
| KR960009643U (ko) | 수경재배 겸용 양액재배용 베드 | |
| NO902346D0 (no) | Organisk fosfitt og fremgangsmaate for dets fremstilling. | |
| KR960003584U (ko) | 분재 소재 배양분 | |
| KR960000029U (ko) | 수경재배 및 양액재배용 베드 | |
| NO972516D0 (no) | Biologisk reinseanlegg for CO2 | |
| KR970011768U (ko) | 양액 재배용 발포스치로폴 베드 |